Boilerplate clauses

Boilerplate clauses

This subtopic focuses on boilerplate clauses in commercial business-to-business agreements. For information on commercial clauses more generally, see: Commercial clauses—overview.

For information on boilerplate in business-to-consumer contracts, see the section on ‘Consumer boilerplate’ below.

For information on boilerplate in public sector contracts, see the section on ‘Public sector boilerplate’ below.

The role of boilerplate

Lawyers work on a huge variety of transactions, but all of them will in some way involve written agreements. All of those agreements should contain some boilerplate clauses.

‘Boilerplate’ is the term used to describe the clauses that are included in an agreement to deal with the mechanics of how it works and those legal points that are relevant to most transactions. For further consideration of the role and importance of boilerplate clauses, see Practice Note: The role of boilerplate.

Boilerplate clauses are generally found at the beginning and the end of an agreement. Such clauses are often thought of as standard, miscellaneous provisions, but this is a very dangerous view to adopt. It is not unusual for a boilerplate clause to be the cause of litigation. Since a boilerplate clause

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

TAKE A FREE TRIAL

Latest Life Sciences News

European Commission adopts 2026 Work Programme

The European Commission has adopted its 2026 Work Programme, Europe’s Independence Moment, setting out a new plan for Europe’s sustainable prosperity, competitiveness, and resilience. Building on its previous efforts under the 2024–2029 Political Guidelines, the 2026 Work Programme aims to strengthen Europe’s technological autonomy, energy security, and social cohesion while driving simplification and competitiveness across all sectors.

DSIT unveils regional innovation investment

The Department for Science, Innovation and Technology (DSIT) has announced a funding boost for regional science and technology sectors, allocating an additional £20m each to Greater Manchester, the West Midlands and the Glasgow City Region. This brings their total support to £50m per region under the Local Innovation Partnerships Fund (LIPF), aimed at accelerating local innovation in areas such as life sciences, clean energy and artificial intelligence (AI). The funding precedes the upcoming Regional Investment Summit in Birmingham and is part of the broader £500m LIPF initiative. The government is also inviting further bids from other UK regions to support high-potential innovation clusters.

EMA launches social media campaign with content creators on GLP-1 medicines

The European Medicines Agency (EMA) has launched its first social media campaign working with content creators to promote safe use of GLP-1 receptor agonists. The #HealthNotHype campaign partners with healthcare professionals and nutrition experts from seven EU Member States on Instagram to address misinformation about these diabetes and weight management medicines. The month-long campaign, which began on 21 October 2025, involves content creators with a combined following of approximately 1.4 million users posting audiovisual content and conducting interactive polls. EMA selected creators based on their credibility in healthcare communication and alignment with evidence-based information principles. Separately, the European Federation of Pharmaceutical Industries and Associations (EFPIA) announced a partnership with TikTok on 21 October 2025 to combat counterfeit medicine sales through its 'Don't fall for dupes' campaign, highlighting that over 50% of medicines sold online are counterfeit.

DHSC and NHS England publish NHS AI trial findings showing time savings and better care

The Department of Health and Social Care (DHSC) and NHS England have published findings from the world’s largest healthcare AI trial, involving more than 30,000 NHS staff across 90 organisations, demonstrating that Microsoft 365 Copilot could save around 400,000 staff hours a month—an average 43 minutes per employee per day—and deliver significant annual cost savings. The AI tool automates administrative tasks such as note-taking, meeting summaries and email management, freeing staff to focus on patient care. The initiative, forming part of the government’s 10 Year Health Plan and Plan for Change, supports the NHS’s digital transformation and coincides with a 2.7 percent rise in acute-trust productivity. Microsoft Copilot Chat is now available across the NHS, extending use to more than 50,000 staff.